PRIME GRANT

NU2GGH002188

Cooperative Agreement

Overview

Awardee
Grant Description
Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in the Republic of South Africa under PEPFAR.
Grant Program (CFDA)
Place of Performance
South Africa
Geographic Scope
Foreign
Notes
COVID-19 $650,000 (1%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Amendment Since initial award the total obligations have increased 1646% from $2,925,074 to $51,078,136.
TB Hiv Care was awarded Cooperative Agreement NU2GGH002188 worth $51,078,136 from Center for Global Health in September 2019. The grant has a duration of 5 years and was awarded through assistance program 93.067 Global AIDS.

Status
(Ongoing)

Last Modified 9/20/23

Period of Performance
9/30/19
Start Date
9/29/24
End Date
80.0% Complete

Funding Split
$51.1M
Federal Obligation
$0.0
Non-Federal Obligation
$51.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Subgrant Awards

Disclosed subgrants for NU2GGH002188

Transaction History

Modifications to NU2GGH002188

Additional Detail

Award ID FAIN
NU2GGH002188
SAI Number
NU2GGH002188-906369740
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
75CDC1 CDC OFFICE OF FINANCIAL RESOURCES
Funding Office
75CW00 CDC CENTER FOR GLOBAL HEALTH
Performance District
Not Applicable
Modified: 9/20/23